Literature DB >> 19885867

The nucleosome binding protein HMGN3 is expressed in pancreatic alpha-cells and affects plasma glucagon levels in mice.

Toshihiro Kurahashi1, Takashi Furusawa, Tetsuya Ueda, Michael Bustin.   

Abstract

Glucose homeostasis requires the coordinated actions of various organs and is critically dependent on the proper functioning of the various cell types present in the pancreatic Langerhans islets. Here we report that chromatin architectural protein HMGN3 is highly expressed in all pancreatic endocrine islet cells, and that Hmgn3-/- mice which have a mild diabetic phenotype, have reduced glucagon levels in their blood. To elucidate the mechanism leading to altered glucagon secretion of Hmgn3-/- mice, we tested whether HMGN3 affect glucagon synthesis and secretion in alphaTC1-9 cells, a glucagon secreting cell line that is used to study pancreatic alpha-cell function. We find that in these cells deletion of either HMGN3 or other HMGN variants, does not significantly affect glucagon gene expression or glucagon secretion. Our studies demonstrate a link between HMGN3 and glucagon blood levels that is not directly dependent of the function of pancreatic alpha-cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19885867      PMCID: PMC3402347          DOI: 10.1002/jcb.22377

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  22 in total

1.  Chromatin unfolding and activation by HMGN(*) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-07       Impact factor: 13.807

2.  Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.

Authors:  J H Johnson; A Ogawa; L Chen; L Orci; C B Newgard; T Alam; R H Unger
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

Review 3.  Somatostatin--both hormone and neurotransmitter?

Authors:  R Luft; S Efendić; T Hökfelt
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

4.  Stimulation of replication efficiency of a chromatin template by chromosomal protein HMG-17.

Authors:  B Vestner; M Bustin; C Gruss
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

5.  Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.

Authors:  M T Guillam; E Hümmler; E Schaerer; J I Yeh; M J Birnbaum; F Beermann; A Schmidt; N Dériaz; B Thorens; J Y Wu
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

6.  Glucose uptake, utilization, and signaling in GLUT2-null islets.

Authors:  M T Guillam; P Dupraz; B Thorens
Journal:  Diabetes       Date:  2000-09       Impact factor: 9.461

Review 7.  Glucagon as a target for the treatment of Type 2 diabetes.

Authors:  Kyle W Sloop; M Dodson Michael; Julie S Moyers
Journal:  Expert Opin Ther Targets       Date:  2005-06       Impact factor: 6.902

8.  Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes.

Authors:  A Valera; G Solanes; J Fernández-Alvarez; A Pujol; J Ferrer; G Asins; R Gomis; F Bosch
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

9.  Chromosomal protein HMGN1 modulates histone H3 phosphorylation.

Authors:  Jae-Hwan Lim; Frédéric Catez; Yehudit Birger; Katherine L West; Marta Prymakowska-Bosak; Yuri V Postnikov; Michael Bustin
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

10.  Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.

Authors:  H Sakurai; R Dobbs; R H Unger
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  7 in total

1.  High mobility group N proteins modulate the fidelity of the cellular transcriptional profile in a tissue- and variant-specific manner.

Authors:  Jamie E Kugler; Marion Horsch; Di Huang; Takashi Furusawa; Mark Rochman; Lillian Garrett; Lore Becker; Alexander Bohla; Sabine M Hölter; Cornelia Prehn; Birgit Rathkolb; Ildikó Racz; Juan Antonio Aguilar-Pimentel; Thure Adler; Jerzy Adamski; Johannes Beckers; Dirk H Busch; Oliver Eickelberg; Thomas Klopstock; Markus Ollert; Tobias Stöger; Eckhard Wolf; Wolfgang Wurst; Ali Önder Yildirim; Andreas Zimmer; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Benny Garfinkel; Joseph Orly; Ivan Ovcharenko; Michael Bustin
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

Review 2.  The HMGN family of chromatin-binding proteins: dynamic modulators of epigenetic processes.

Authors:  Jamie E Kugler; Tao Deng; Michael Bustin
Journal:  Biochim Biophys Acta       Date:  2012-02-02

3.  The mediating effect of DNA methylation in the association between maternal sleep during pregnancy and offspring adiposity status: a prospective cohort study.

Authors:  Min Meng; Yanrui Jiang; Jianfei Lin; Jun Zhang; Guanghai Wang; Qi Zhu; Qingmin Lin; Fan Jiang
Journal:  Clin Epigenetics       Date:  2022-05-20       Impact factor: 7.259

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 5.  Biological Functions of HMGN Chromosomal Proteins.

Authors:  Ravikanth Nanduri; Takashi Furusawa; Michael Bustin
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

6.  Cap-independent translation by DAP5 controls cell fate decisions in human embryonic stem cells.

Authors:  Yael Yoffe; Maya David; Rinat Kalaora; Lital Povodovski; Gilgi Friedlander; Ester Feldmesser; Elena Ainbinder; Ann Saada; Shani Bialik; Adi Kimchi
Journal:  Genes Dev       Date:  2016-09-01       Impact factor: 11.361

7.  Revealing potential diagnostic gene biomarkers of septic shock based on machine learning analysis.

Authors:  Yonghua Fan; Qiufeng Han; Jinfeng Li; Gaige Ye; Xianjing Zhang; Tengxiao Xu; Huaqing Li
Journal:  BMC Infect Dis       Date:  2022-01-19       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.